Globus Medical (GMED) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Leerink Partners Reiterates Outperform Following Globus Medical's (GMED) Strong 4Q
February 25, 2016 7:26 AM ESTLeerink Partners maintained an Outperform rating on Globus Medical (NYSE: GMED), and cut the price target to $29.00 (from $32.00), following the company's 4Q earnings report. Revenue of ~$142.6M was in line with the January preannouncement and ~$4M above the Street. GMED also delivered... More
